Tokio Marine Asset Management’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-3,973
| Closed | -$965K | – | 565 |
|
|
2024
Q2 | $965K | Buy |
3,973
+124
| +3% | +$30.1K | 0.05% | 278 |
|
|
2024
Q1 | $575K | Buy |
3,849
+274
| +8% | +$40.9K | 0.03% | 397 |
|
|
2023
Q4 | $684K | Buy |
3,575
+195
| +6% | +$37.3K | 0.04% | 324 |
|
|
2023
Q3 | $599K | Buy |
3,380
+309
| +10% | +$54.7K | 0.04% | 320 |
|
|
2023
Q2 | $583K | Buy |
3,071
+204
| +7% | +$38.7K | 0.04% | 326 |
|
|
2023
Q1 | $574K | Buy |
2,867
+474
| +20% | +$95K | 0.04% | 308 |
|
|
2022
Q4 | $569K | Buy |
2,393
+201
| +9% | +$47.8K | 0.04% | 281 |
|
|
2022
Q3 | $439K | Buy |
2,192
+110
| +5% | +$22K | 0.04% | 300 |
|
|
2022
Q2 | $304K | Buy |
2,082
+374
| +22% | +$54.6K | 0.03% | 371 |
|
|
2022
Q1 | $279K | Buy |
1,708
+168
| +11% | +$27.4K | 0.02% | 394 |
|
|
2021
Q4 | $261K | Sell |
1,540
-7
| -0.5% | -$1.19K | 0.02% | 420 |
|
|
2021
Q3 | $292K | Buy |
1,547
+263
| +20% | +$49.6K | 0.03% | 346 |
|
|
2021
Q2 | $218K | Buy |
+1,284
| New | +$218K | 0.02% | 407 |
|